Omicron in India LIVE updates| 26 new Omicron cases detected in Maharashtra moment, 12 in Telangana
Omicron cases in India The number of Omicron cases in India rose to 578 on Monday. A number of countries, including Kerala, Uttarakhand, and Delhi, have assessed night curfew to control the spread of the contagion. Meanwhile, the government issued sanctioned guidelines on vaccination for children in the 15-18 age group and supporter shots on Monday. Stay tuned for LIVE updates on the Omicron situation in India and abroad.
What’s the Omicron variant?
The Omicron variant of COVID-19 has been called a variant of concern by WHO grounded on the substantiation that it has several mutations that may have an impact on how it behaves. There’s still substantial query regarding Omicron and a lot of exploration underway to estimate its transmissibility, inflexibility, and reinfection threat.
Is the Omicron variant more contagious?
Omicron is spreading more snappily than other variants. Grounded on the information available, WHO believes it’s likely that Omicron will outpace the Delta variant where there’s COVID-19 transmission in the community.
Still, being vaccinated and taking preventives similar to avoiding crowded spaces, keeping your distance from others, and wearing a mask is critical in helping to help the spread of COVID-19, and we know these conduct have been effective against other variants.
Does the Omicron variant cause different symptoms?
There’s no information to suggest that Omicron causes different COVID-19 symptoms from other COVID-19 variants.
How can I talk to my child about the Omicron and other COVID-19 variants?
News about COVID-19 and now the Omicron variant is submerging our diurnal lives and it’s only natural that curious youthful children will have questions – lots of them. Then are some pointers to keep in mind tips for helping to explain what can be complicated content in simple and reassuring terms.
Children have a right to know what’s going on, but it should be explained to them in an age-applicable way.
Invite your child to partake what they’ve heard and heard to their responses. It’s important to be completely engaged and take any fears they’ve seriously. Be patient, the epidemic and misinformation have caused a lot of solicitude and query for everyone.
Make sure that you’re up to date on the rearmost information yourself. Websites of transnational associations like UNICEF and the World Health Organization are great sources of information about the epidemic.
Still, don’t guess, If you don’t know the answer. Use it as an occasion to explore the answers together.
Remember that kiddies take their emotional cues from grown-ups, so indeed if you’re upset for your little one knowing that they might be uncomfortable, try not to overshare your fears with your child.
Are the COVID-19 vaccines effective against the Omicron variant?
Experimenters are looking into any implicit impact the Omicron variant has on the effectiveness of COVID-19 vaccines. Information is still limited, but there may be a small reduction in the effectiveness of vaccines against severe illness and death and a decline in precluding mild complaints and infection. Still, WHO reports that so far it looks like the presently available vaccines offer significant protection against severe complaints and death.
It’s also important to be vaccinated to cover against the other extensively circulating variants, similar to the Delta one. When it’s your turn, make sure to get vaccinated. However, it’s important to admit both in order to have the maximum protection, If your vaccination involves two boluses.
How did the Omicron variant develop?
When a contagion is circulating extensively and causing multitudinous infections, the liability of the contagion shifting increases. The further openings a contagion has to spread, the further openings it has to suffer changes.
New variants like Omicron are a memorial that the COVID-19 epidemic is far from over. It’s thus essential that people get the vaccine when available to them and continue to follow being advice on precluding the spread of the contagion, including physical distancing, wearing masks, regular handwashing and keeping inner areas well voiced.
It’s also pivotal that vaccines and other public health measures are accessible every place. Vaccine inequity leaves lower-income countries – numerous of them in Africa – at the mercy of COVID-19. Well-supplied countries must urgently deliver the boluses they promised.
Where is the Omicron variant present?
The Omicron variant has now been detected in numerous countries around the world. WHO reports that Omicron is presumably in utmost countries, indeed if it hasn’t been detected yet.
Is the Omicron variant more severe than other COVID-19 variants?
Early findings suggest that Omicron might be less severe than the Delta variant, but more data is demanded, and WHO warns that it shouldn’t be dismissed as “ mild”. Studies are ongoing and this information will be streamlined as it becomes available.
It’s important to remember that all variants of COVID-19 can beget severe complaints or death, including the Delta variant that’s still dominant worldwide, which is why precluding the spread of the contagion and reducing your threat of exposure to the contagion is so important.
- Wear a mask that covers your nose and mouth. Make sure that your hands are clean when you put on and remove your mask.
- Keep a physical distance of at least 1 meter from others.
- Avoid Inadequately voiced or crowded spaces.
- Open windows to ameliorate ventilation indoors.
- Wash your hands regularly.
- When it’s your turn, get vaccinated. WHO-approved COVID-19 vaccines are safe and effective.
The Technical Advisory Group on SARS-CoV-2 Virus Evolution ( Label-VE) is an independent group of experts that periodically monitors and evaluates the elaboration of SARS-CoV-2 and assesses if specific mutations and combinations of mutations alter the geste of the contagion. The Label-VE was convened on 26 November 2021 to assess the SARS-CoV-2 variantB.1.1.529.
TheB.1.1.529 variant was first reported to WHO from South Africa on 24 November 2021. The epidemiological situation in South Africa has been characterized by three distinct peaks in reported cases, the rearmost of which was generally the Delta variant. In recent weeks, infections have increased acutely, coinciding with the discovery ofB.1.1.529 variant. The first known verified.1.1.529 infection was from an instance collected on 9 November 2021.
This variant has a large number of mutations, some of which are concerning. Primary substantiation suggests an increased threat of reinfection with this variant, as compared to other VOCs. The number of cases of this variant appears to be adding in nearly all businesses in South Africa. Current SARS-CoV-2 PCR diagnostics continue to descry this variant. Several labs have indicated that for one extensively habituated PCR test, one of the three target genes isn’t detected ( called S gene powerhouse or S gene target failure) and this test can thus be used as a marker for this variant, pending sequencing evidence. Using this approach, this variant has been detected at faster rates than former surges in infection, suggesting that this variant may have a growth advantage.
There are a number of studies underway and the Label-VE will continue to estimate this variant. WHO will communicate new findings with the Member States and to the public as demanded.
Grounded on the substantiation presented reflective of a mischievous change in COVID-19 epidemiology, the Label-VE has advised WHO that this variant should be designated as a VOC, and the WHO has designatedB.1.1.529 as a VOC, named Omicron.
As similar, countries are asked to do the following. enhance surveillance and sequencing sweats to more understand circulating SARS-CoV-2 variants.
submit complete genome sequences and associated metadata to an intimately available database, similar as GISAID.
report original cases/ clusters associated with VOC infection to WHO through the IHR medium.
where capacity exists and in collaboration with the transnational community, perform field examinations and laboratory assessments to ameliorate understanding of the implicit impacts of the VOC on COVID-19 epidemiology, inflexibility, the effectiveness of public health and social measures, individual styles, vulnerable responses, antibody neutralization, or other applicable characteristics.
Individualities are reminded to take measures to reduce their threat of COVID-19, including proven public health and social measures similar as wearing well-befitting masks, hand hygiene, physical distancing, perfecting ventilation of inner spaces, avoiding crowded spaces, and getting vaccinated.
For reference, WHO has working delineations for SARS-CoV-2 Variant of Interest (VOI) and Variant of Concern (VOC).
A SARS-CoV-2 VOI is a SARS-CoV-2 variant
with inheritable changes that are prognosticated or known to affect contagion characteristics similar as transmissibility, complaint inflexibility, vulnerable escape, individual or remedial escape; AND
. that has been linked as causing significant community transmission or multiple COVID-19 clusters, in multiple countries with adding relative frequency alongside adding a number of cases over time, or other apparent epidemiological impacts to suggest an arising threat to global public health.
A SARS-CoV-2 VOC is a SARS-CoV-2 variant that meets the description of a VOI ( see over) and, through a relative assessment, has been demonstrated to be associated with one or further of the following changes at a degree of global public health significance
increase in transmissibility or mischievous change in COVID-19 epidemiology; OR
increase in acridity or change in clinical complaint donation; OR
Drop ineffectiveness of public health and social measures or available diagnostics, vaccines, rectifiers
Source of this information is Who.com.